BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 23008313)

  • 1. Tumor grade is associated with venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study.
    Ahlbrecht J; Dickmann B; Ay C; Dunkler D; Thaler J; Schmidinger M; Quehenberger P; Haitel A; Zielinski C; Pabinger I
    J Clin Oncol; 2012 Nov; 30(31):3870-5. PubMed ID: 23008313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study.
    Ay C; Vormittag R; Dunkler D; Simanek R; Chiriac AL; Drach J; Quehenberger P; Wagner O; Zielinski C; Pabinger I
    J Clin Oncol; 2009 Sep; 27(25):4124-9. PubMed ID: 19636003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of mean platelet volume with risk of venous thromboembolism and mortality in patients with cancer. Results from the Vienna Cancer and Thrombosis Study (CATS).
    Riedl J; Kaider A; Reitter EM; Marosi C; Jäger U; Schwarzinger I; Zielinski C; Pabinger I; Ay C
    Thromb Haemost; 2014 Apr; 111(4):670-8. PubMed ID: 24306221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High factor VIII levels independently predict venous thromboembolism in cancer patients: the cancer and thrombosis study.
    Vormittag R; Simanek R; Ay C; Dunkler D; Quehenberger P; Marosi C; Zielinski C; Pabinger I
    Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2176-81. PubMed ID: 19778945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble Vascular Endothelial Growth Factor (sVEGF) and the Risk of Venous Thromboembolism in Patients with Cancer: Results from the Vienna Cancer and Thrombosis Study (CATS).
    Posch F; Thaler J; Zlabinger GJ; Königsbrügge O; Koder S; Zielinski C; Pabinger I; Ay C
    Clin Cancer Res; 2016 Jan; 22(1):200-6. PubMed ID: 26302981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk cancer patients undergoing chemotherapy in the United States.
    Khorana AA; Dalal M; Lin J; Connolly GC
    Cancer; 2013 Feb; 119(3):648-55. PubMed ID: 22893596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statins are associated with low risk of venous thromboembolism in patients with cancer: a prospective and observational cohort study.
    Lötsch F; Königsbrügge O; Posch F; Zielinski C; Pabinger I; Ay C
    Thromb Res; 2014 Nov; 134(5):1008-13. PubMed ID: 25234407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of venous thromboembolism in patients with ovarian cancer undergoing platinum/paclitaxel-containing first-line chemotherapy: an exploratory analysis by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group.
    Fotopoulou C; duBois A; Karavas AN; Trappe R; Aminossadati B; Schmalfeldt B; Pfisterer J; Sehouli J;
    J Clin Oncol; 2008 Jun; 26(16):2683-9. PubMed ID: 18509180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical analysis of postoperative venous thromboembolism risk factors in lung cancer patients.
    Yang Y; Zhou Z; Niu XM; Li ZM; Chen ZW; Jian H; Ai XH; Cheng BJ; Liao ML; Lu S
    J Surg Oncol; 2012 Nov; 106(6):736-41. PubMed ID: 22711667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study.
    Khorana AA; Francis CW; Culakova E; Lyman GH
    Cancer; 2005 Dec; 104(12):2822-9. PubMed ID: 16284987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of fibrinogen plasma levels, the -455G>A fibrinogen and the factor XIII A subunit (FXIII-A) Val34Leu polymorphism in cancer-associated venous thrombosis.
    Tiedje V; Dunkler D; Ay C; Horvath B; Quehenberger P; Pabinger M; Zielinski C; Pabinger I; Mannhalter C
    Thromb Haemost; 2011 Nov; 106(5):908-13. PubMed ID: 21901234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intratumoral tissue factor expression and risk of venous thromboembolism in brain tumor patients.
    Thaler J; Preusser M; Ay C; Kaider A; Marosi C; Zielinski C; Pabinger I; Hainfellner JA
    Thromb Res; 2013 Feb; 131(2):162-5. PubMed ID: 23084660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and predictors of venous thromboembolism in post-acute care patients. A prospective cohort study.
    Scannapieco G; Ageno W; Airoldi A; Bonizzoni E; Campanini M; Gussoni G; Silingardi M; Valerio A; Zilli C; Iori I;
    Thromb Haemost; 2010 Oct; 104(4):734-40. PubMed ID: 20664897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and risk factors of symptomatic venous thromboembolism related to implanted ports in cancer patients.
    Piran S; Ngo V; McDiarmid S; Le Gal G; Petrcich W; Carrier M
    Thromb Res; 2014 Jan; 133(1):30-3. PubMed ID: 24188799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postoperative venous thromboembolism predicts survival in cancer patients.
    Auer RA; Scheer AS; McSparron JI; Schulman AR; Tuorto S; Doucette S; Gonsalves J; Fong Y
    Ann Surg; 2012 May; 255(5):963-70. PubMed ID: 22504195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The incidence of venous thromboembolism and its effect on survival among patients with primary bladder cancer.
    Sandhu R; Pan CX; Wun T; Harvey D; Zhou H; White RH; Chew HK
    Cancer; 2010 Jun; 116(11):2596-603. PubMed ID: 20336780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rates of venous thromboembolism occurrence in medical patients among the insured population.
    Spyropoulos AC; Hussein M; Lin J; Battleman D
    Thromb Haemost; 2009 Nov; 102(5):951-7. PubMed ID: 19888534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors and clinical impact of postoperative symptomatic venous thromboembolism.
    Gangireddy C; Rectenwald JR; Upchurch GR; Wakefield TW; Khuri S; Henderson WG; Henke PK
    J Vasc Surg; 2007 Feb; 45(2):335-341; discussion 341-2. PubMed ID: 17264013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptomatic perioperative venous thromboembolism is a frequent complication in patients with a history of deep vein thrombosis.
    Liem TK; Huynh TM; Moseley SE; Minjarez RC; Landry GJ; Mitchell EL; Deloughery TG; Moneta GL
    J Vasc Surg; 2010 Sep; 52(3):651-7. PubMed ID: 20558025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying cancer patients at risk for venous thromboembolism.
    Sousou T; Khorana A
    Hamostaseologie; 2009 Jan; 29(1):121-4. PubMed ID: 19151861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.